Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Post author:
Post published:September 13, 2024
Post category:uncategorized

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the need for additional studies.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Breakthrough study uncovers TIP60’s role in DNA access and disease mechanisms

Oxford researchers call for framework to study AI’s impact on youth mental health

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Helpful Links

Subscribe To Us